3-Bromopropylamine is a colorless liquid with a strong ammonia-like odor. It is a useful building block for the synthesis of various organic compounds, including pharmaceuticals, agrochemicals, and polymers. It is typically synthesized by reacting 3-bromopropanol with ammonia. While detailed studies on the biological effects of 3-bromopropylamine are limited, its reactivity with various functional groups suggests potential applications in drug development and other areas. Research on this compound focuses on exploring its potential as a synthetic intermediate and investigating its reactivity in various chemical reactions.'
3-bromopropylamine: an alkylating agent used for identifying cysteine residues [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 78702 |
| SCHEMBL ID | 73729 |
| MeSH ID | M0216372 |
| Synonym |
|---|
| 1.7.6 3-bromanylpropan-1-amine |
| 3-bromopropan-1-amine |
| NCIOPEN2_004413 |
| 3-bromopropylamine |
| 3-aminopropyl bromide |
| BBL010090 |
| AKOS005716279 |
| 1-propanamine, 3-bromo- |
| 18370-81-5 |
| STL145902 |
| BP-20652 |
| 1-propanamine, 3-bromo-(9ci) |
| SCHEMBL73729 |
| 3-bromopropyl amine |
| gamma-bromopropylamine |
| bromopropyl amine |
| bromopropylamine |
| 3-bromo-1-propanamine # |
| 3-aminopropylbromide |
| (3-bromopropyl)amine |
| DTXSID60171467 |
| BS-9880 |
| mfcd00044486 |
| Q27454800 |
| EN300-34847 |
| CS-0434765 |
| PD163262 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (31.55) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||